These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8835282)

  • 1. The effect of caffeine on cue exposure responses in ex-smokers.
    Hepple J; Robson P
    Addiction; 1996 Feb; 91(2):269-73. PubMed ID: 8835282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of caffeine, caffeine-associated stimuli, and caffeine-related information on physiological and psychological arousal.
    Mikalsen A; Bertelsen B; Flaten MA
    Psychopharmacology (Berl); 2001 Oct; 157(4):373-80. PubMed ID: 11605096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the electroencephalographic spectrum in response to smoking cues in smokers and ex-smokers.
    Littel M; Franken IH; Van Strien JW
    Neuropsychobiology; 2009; 59(1):43-50. PubMed ID: 19270463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attentional bias training and cue reactivity in cigarette smokers.
    Attwood AS; O'Sullivan H; Leonards U; Mackintosh B; Munafò MR
    Addiction; 2008 Nov; 103(11):1875-82. PubMed ID: 19032536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
    Nørregaard J; Jørgensen S; Mikkelsen KL; Tønnesen P; Iversen E; Sørensen T; Søeberg B; Jakobsen HB
    Clin Pharmacol Ther; 1996 Dec; 60(6):679-86. PubMed ID: 8988071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of caffeine's impact on autonomic and central nervous system measures: clarification of arousal effects.
    Barry RJ; Clarke AR; Johnstone SJ; Rushby JA
    Biol Psychol; 2008 Mar; 77(3):304-16. PubMed ID: 18093716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine effects on resting-state arousal.
    Barry RJ; Rushby JA; Wallace MJ; Clarke AR; Johnstone SJ; Zlojutro I
    Clin Neurophysiol; 2005 Nov; 116(11):2693-700. PubMed ID: 16221568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic affective responses to smoking cues.
    Payne BK; McClernon FJ; Dobbins IG
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):400-9. PubMed ID: 17696687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial.
    Marissen MA; Franken IH; Blanken P; van den Brink W; Hendriks VM
    Psychother Psychosom; 2007; 76(2):97-105. PubMed ID: 17230050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain.
    Pomerleau OF; Pomerleau CS; Mehringer AM; Snedecor SM; Ninowski R; Sen A
    Nicotine Tob Res; 2005 Feb; 7(1):91-102. PubMed ID: 15804681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study.
    Zhou X; Nonnemaker J; Sherrill B; Gilsenan AW; Coste F; West R
    Addict Behav; 2009 Apr; 34(4):365-73. PubMed ID: 19097706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.
    Shi J; Jun W; Zhao LY; Xue YX; Zhang XY; Kosten TR; Lu L
    Eur J Pharmacol; 2009 Aug; 615(1-3):108-12. PubMed ID: 19470385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of prolonged abstinence on the processing of smoking cues: an ERP study among smokers, ex-smokers and never-smokers.
    Littel M; Franken IH
    J Psychopharmacol; 2007 Nov; 21(8):873-82. PubMed ID: 17984163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal.
    Swanson JA; Lee JW; Hopp JW
    Addict Behav; 1994; 19(3):229-56. PubMed ID: 7942243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist.
    Fonder MA; Sacco KA; Termine A; Boland BS; Seyal AA; Dudas MM; Vessicchio JC; George TP
    Biol Psychiatry; 2005 Apr; 57(7):802-8. PubMed ID: 15820238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective and physiological responses to smoking cues in smokers with schizophrenia.
    Tidey JW; Rohsenow DJ; Kaplan GB; Swift RM
    Nicotine Tob Res; 2005 Jun; 7(3):421-9. PubMed ID: 16085510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mecamylamine moderates cue-induced emotional responses in smokers.
    McClernon FJ; Rose JE
    Addict Behav; 2005 May; 30(4):741-53. PubMed ID: 15833578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
    Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.